Virus-like particle (VLP)-based vaccines for pandemic influenza

References

• Fedson DS. Vaccine development for an imminent pandemic: why we should worry, what we must do. Hum Vaccin 2006; 2:38 - 42; http://dx.doi.org/10.4161/hv.2.1.2554; PMID: 17012898
   PubMed Web of Science ®Google Scholar
• European 2009 influenza pandemic timeline, 2010. (http://ecdc.europa.eu/en/healthtopics/H1N1/Documents/110810_2009_pandemic_European_Timeline.pdf).
   Google Scholar
• Chowell G, Echevarría-Zuno S, Viboud C, Simonsen L, Tamerius J, Miller MA, et al. Characterizing the epidemiology of the 2009 influenza A/H1N1 pandemic in Mexico. PLoS Med 2011; 8:e1000436; http://dx.doi.org/10.1371/journal.pmed.1000436; PMID: 21629683
   PubMed Web of Science ®Google Scholar
• Charu V, Chowell G, Palacio Mejia LS, Echevarría-Zuno S, Borja-Aburto VH, Simonsen L, et al. Mortality burden of the A/H1N1 pandemic in Mexico: a comparison of deaths and years of life lost to seasonal influenza. Clin Infect Dis 2011; 53:985 - 93; http://dx.doi.org/10.1093/cid/cir644; PMID: 21976464
   PubMed Web of Science ®Google Scholar
• Girard MP, Tam JS, Assossou OM, Kieny MP. The 2009 A (H1N1) influenza virus pandemic: A review. Vaccine 2010; 28:4895 - 902; http://dx.doi.org/10.1016/j.vaccine.2010.05.031; PMID: 20553769
   PubMed Web of Science ®Google Scholar
• Vidal P, Reyna J, Saldaña P, Richardson VL. Events temporarily associated with anti-influenza A (H1N1) vaccination in Mexico. Arch Med Res 2011; 42:627 - 32; http://dx.doi.org/10.1016/j.arcmed.2011.10.007; PMID: 22036935
   PubMed Web of Science ®Google Scholar
• Manzoli L, De Vito C, Salanti G, D’Addario M, Villari P, Ioannidis JP. Meta-analysis of the immunogenicity and tolerability of pandemic influenza A 2009 (H1N1) vaccines. PLoS One 2011; 6:e24384; http://dx.doi.org/10.1371/journal.pone.0024384; PMID: 21915319
   PubMed Web of Science ®Google Scholar
• Osterholm MTKN, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12:36 - 44; http://dx.doi.org/10.1016/S1473-3099(11)70295-X; PMID: 22032844
   PubMed Web of Science ®Google Scholar
• Kang SM, Song JM, Quan FS, Compans RW. Influenza vaccines based on virus-like particles. Virus Res 2009; 143:140 - 6; http://dx.doi.org/10.1016/j.virusres.2009.04.005; PMID: 19374929
   PubMed Web of Science ®Google Scholar
• Plummer EM, Manchester M. Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2010:174-96.
   Google Scholar
• Buonaguro L, Tornesello ML, Tagliamonte M, Gallo RC, Wang LX, Kamin-Lewis R, et al. Baculovirus-derived human immunodeficiency virus type 1 virus-like particles activate dendritic cells and induce ex vivo T-cell responses. J Virol 2006; 80:9134 - 43; http://dx.doi.org/10.1128/JVI.00050-06; PMID: 16940524
   PubMed Web of Science ®Google Scholar
• Acosta-Ramírez E, Pérez-Flores R, Majeau N, Pastelin-Palacios R, Gil-Cruz C, Ramírez-Saldaña M, et al. Translating innate response into long-lasting antibody response by the intrinsic antigen-adjuvant properties of papaya mosaic virus. Immunology 2008; 124:186 - 97; http://dx.doi.org/10.1111/j.1365-2567.2007.02753.x; PMID: 18070030
   PubMed Web of Science ®Google Scholar
• Sailaja G, Skountzou I, Quan FS, Compans RW, Kang SM. Human immunodeficiency virus-like particles activate multiple types of immune cells. Virology 2007; 362:331 - 41; http://dx.doi.org/10.1016/j.virol.2006.12.014; PMID: 17276476
   PubMed Web of Science ®Google Scholar
• Bachmann MF, Rohrer UH, Kündig TM, Bürki K, Hengartner H, Zinkernagel RM. The influence of antigen organization on B cell responsiveness. Science 1993; 262:1448 - 51; http://dx.doi.org/10.1126/science.8248784; PMID: 8248784
   PubMed Web of Science ®Google Scholar
• Bachmann MF, Jennings GT. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat Rev Immunol 2010; 10:787 - 96; http://dx.doi.org/10.1038/nri2868; PMID: 20948547
   PubMed Web of Science ®Google Scholar
• Denis J, Acosta-Ramirez E, Zhao Y, Hamelin ME, Koukavica I, Baz M, et al. Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform. Vaccine 2008; 26:3395 - 403; http://dx.doi.org/10.1016/j.vaccine.2008.04.052; PMID: 18511159
   PubMed Web of Science ®Google Scholar
• Haynes JR. Influenza virus-like particle vaccines. Expert Rev Vaccines 2009; 8:435 - 45; http://dx.doi.org/10.1586/erv.09.8; PMID: 19348559
   PubMed Web of Science ®Google Scholar
• Cox MM. Progress on baculovirus-derived influenza vaccines. Curr Opin Mol Ther 2008; 10:56 - 61; PMID: 18228182
   PubMed Web of Science ®Google Scholar
• Bright RA, Carter DM, Daniluk S, Toapanta FR, Ahmad A, Gavrilov V, et al. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin. Vaccine 2007; 25:3871 - 8; http://dx.doi.org/10.1016/j.vaccine.2007.01.106; PMID: 17337102
   PubMed Web of Science ®Google Scholar
• Latham T, Galarza JM. Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins. J Virol 2001; 75:6154 - 65; http://dx.doi.org/10.1128/JVI.75.13.6154-6165.2001; PMID: 11390617
   PubMed Web of Science ®Google Scholar
• Bright RA, Carter DM, Crevar CJ, Toapanta FR, Steckbeck JD, Cole KS, et al. Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle. PLoS One 2008; 3:e1501.
   Google Scholar
• Pushko P, Tumpey TM, Bu F, Knell J, Robinson R, Smith G. Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice. Vaccine 2005; 23:5751 - 9; http://dx.doi.org/10.1016/j.vaccine.2005.07.098; PMID: 16143432
   PubMed Web of Science ®Google Scholar
• Pushko P, Tumpey TM, Van Hoeven N, Belser JA, Robinson R, Nathan M, et al. Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenza. Vaccine 2007; 25:4283 - 90; http://dx.doi.org/10.1016/j.vaccine.2007.02.059; PMID: 17403562
   PubMed Web of Science ®Google Scholar
• Galarza JM, Latham T, Cupo A. Virus-like particle vaccine conferred complete protection against a lethal influenza virus challenge. Viral Immunol 2005; 18:365 - 72; http://dx.doi.org/10.1089/vim.2005.18.365; PMID: 16035948
   PubMed Web of Science ®Google Scholar
• Quan FS, Huang C, Compans RW, Kang SM. Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus. J Virol 2007; 81:3514 - 24; http://dx.doi.org/10.1128/JVI.02052-06; PMID: 17251294
   PubMed Web of Science ®Google Scholar
• Kang SM, Pushko P, Bright RA, Smith G, Compans RW. Influenza virus-like particles as pandemic vaccines. Curr Top Microbiol Immunol 2009; 333:269 - 89; http://dx.doi.org/10.1007/978-3-540-92165-3_14; PMID: 19768411
   PubMedGoogle Scholar
• Hossain MJ, Bourgeois M, Quan FS, Lipatov AS, Song JM, Chen LM, et al. Virus-like particle vaccine containing hemagglutinin confers protection against 2009 H1N1 pandemic influenza. Clin Vaccine Immunol 2011; 18:2010 - 7; http://dx.doi.org/10.1128/CVI.05206-11; PMID: 22030367
   PubMed Web of Science ®Google Scholar
• Landry N, Ward BJ, Trépanier S, Montomoli E, Dargis M, Lapini G, et al. Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza. PLoS One 2010; 5:e15559; http://dx.doi.org/10.1371/journal.pone.0015559; PMID: 21203523
   PubMed Web of Science ®Google Scholar
• Pushko P, Kort T, Nathan M, Pearce MB, Smith G, Tumpey TM. Recombinant H1N1 virus-like particle vaccine elicits protective immunity in ferrets against the 2009 pandemic H1N1 influenza virus. Vaccine 2010; 28:4771 - 6; http://dx.doi.org/10.1016/j.vaccine.2010.04.093; PMID: 20470801
   PubMed Web of Science ®Google Scholar
• López-Macías C, Ferat-Osorio E, Tenorio-Calvo A, Isibasi A, Talavera J, Arteaga-Ruiz O, et al. Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico. Vaccine 2011; 29:7826 - 34; http://dx.doi.org/10.1016/j.vaccine.2011.07.099; PMID: 21816199
   PubMed Web of Science ®Google Scholar